Literature DB >> 20416862

Behavioral and functional evidence of metabotropic glutamate receptor 2/3 and metabotropic glutamate receptor 5 dysregulation in cocaine-escalated rats: factor in the transition to dependence.

Yue Hao1, Rémi Martin-Fardon, Friedbert Weiss.   

Abstract

BACKGROUND: Rats with extended daily cocaine access show escalating cocaine self-administration and behavioral signs of dependence. Regulation of glutamatergic transmission by metabotropic glutamate receptors has emerged as a mechanism in the addictive actions of drugs of abuse. We examined here whether neuroadaptive dysregulation of metabotropic glutamate receptor function is a factor in escalating cocaine self-administration.
METHODS: Rats with 1 hour daily cocaine access (short access [ShA]) versus 6-hour access (long access [LgA]) were tested for differences in the effects of the metabotropic glutamate receptor 2/3 (mGluR2/3) agonist (-)-2-oxa-4-aminobicylco(3.1.0)hexane-4,6-dicarboxylic acid (LY379268) and the metabotropic glutamate receptor 5 (mGluR5) antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine (MTEP) on cocaine-reinforced progressive-ratio responding and differences in expression levels and functional activity of mGluR2/3 and mGluR5.
RESULTS: The LgA groups showed higher progressive-ratio breakpoints than ShA groups. LY379268 (0-3 mg/kg subcutaneous) dose-dependently lowered breakpoints in the LgA group but reduced breakpoints only at 3 mg/kg in the ShA group. Consistent with this behavioral effect, functional mGluR2/3 activity was significantly elevated following LgA cocaine exposure. MTEP (0-3 mg/kg intraperitoneal) reduced breakpoints in the ShA group only. Long access cocaine exposure was associated with decreased mGluR5 expression, accompanied by reduced functional mGluR5 activity in the nucleus accumbens. A downward trend developed in mGluR5 protein expression in the medial prefrontal cortex and hippocampus.
CONCLUSIONS: Functional upregulation of mGluR2/3 and downregulation of mGluR5 are likely factors in the transition to cocaine dependence. The differential behavioral effects of LY379268 and MTEP in rats with a history of long access to cocaine have implications for the treatment target potential of mGluR2/3 and mGluR5. Copyright 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20416862      PMCID: PMC2907426          DOI: 10.1016/j.biopsych.2010.02.011

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  58 in total

1.  Persistent increase in the motivation to take heroin in rats with a history of drug escalation.

Authors:  S H Ahmed; J R Walker; G F Koob
Journal:  Neuropsychopharmacology       Date:  2000-04       Impact factor: 7.853

2.  Long-lasting increase in the set point for cocaine self-administration after escalation in rats.

Authors:  S H Ahmed; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1999-10       Impact factor: 4.530

3.  Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice.

Authors:  C Chiamulera; M P Epping-Jordan; A Zocchi; C Marcon; C Cottiny; S Tacconi; M Corsi; F Orzi; F Conquet
Journal:  Nat Neurosci       Date:  2001-09       Impact factor: 24.884

Review 4.  An overview on functional receptor autoradiography using [35S]GTPgammaS.

Authors:  J Sóvágó; D S Dupuis; B Gulyás; H Hall
Journal:  Brain Res Brain Res Rev       Date:  2001-12

5.  Agonist-induced internalization of the metabotropic glutamate receptor 1a is arrestin- and dynamin-dependent.

Authors:  S J Mundell; A L Matharu; G Pula; P J Roberts; E Kelly
Journal:  J Neurochem       Date:  2001-08       Impact factor: 5.372

6.  Cocaine and kindling alter the sensitivity of group II and III metabotropic glutamate receptors in the central amygdala.

Authors:  V Neugebauer; F Zinebi; R Russell; J P Gallagher; P Shinnick-Gallagher
Journal:  J Neurophysiol       Date:  2000-08       Impact factor: 2.714

7.  Agonist-stimulated and tonic internalization of metabotropic glutamate receptor 1a in human embryonic kidney 293 cells: agonist-stimulated endocytosis is beta-arrestin1 isoform-specific.

Authors:  L B Dale; M Bhattacharya; J L Seachrist; P H Anborgh; S S Ferguson
Journal:  Mol Pharmacol       Date:  2001-12       Impact factor: 4.436

8.  Repeated cocaine administration attenuates group I metabotropic glutamate receptor-mediated glutamate release and behavioral activation: a potential role for Homer.

Authors:  C J Swanson; D A Baker; D Carson; P F Worley; P W Kalivas
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

Review 9.  Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system.

Authors:  D D Schoepp
Journal:  J Pharmacol Exp Ther       Date:  2001-10       Impact factor: 4.030

10.  A role of ventral tegmental area glutamate in contextual cue-induced relapse to heroin seeking.

Authors:  Jennifer M Bossert; Shirley Y Liu; Lin Lu; Yavin Shaham
Journal:  J Neurosci       Date:  2004-11-24       Impact factor: 6.167

View more
  67 in total

1.  mGlu receptors and drug addiction.

Authors:  Richard M Cleva; M Foster Olive
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2012-01-20

2.  Involvement of metabotropic glutamate receptor 5 in brain reward deficits associated with cocaine and nicotine withdrawal and somatic signs of nicotine withdrawal.

Authors:  Astrid K Stoker; Berend Olivier; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2011-12-03       Impact factor: 4.530

3.  The individual and combined effects of phenmetrazine and mgluR2/3 agonist LY379268 on the motivation to self-administer cocaine.

Authors:  Anushree N Karkhanis; Thomas J R Beveridge; Bruce E Blough; Sara R Jones; Mark J Ferris
Journal:  Drug Alcohol Depend       Date:  2016-06-25       Impact factor: 4.492

4.  Enhanced sensitivity to attenuation of conditioned reinstatement by the mGluR 2/3 agonist LY379268 and increased functional activity of mGluR 2/3 in rats with a history of ethanol dependence.

Authors:  Peter R Kufahl; Rémi Martin-Fardon; Friedbert Weiss
Journal:  Neuropsychopharmacology       Date:  2011-08-31       Impact factor: 7.853

5.  Activation of group II metabotropic glutamate receptors inhibits the discriminative stimulus effects of alcohol via selective activity within the amygdala.

Authors:  Reginald Cannady; Julie J M Grondin; Kristen R Fisher; Clyde W Hodge; Joyce Besheer
Journal:  Neuropsychopharmacology       Date:  2011-07-06       Impact factor: 7.853

Review 6.  Cocaine self-administration causes signaling deficits in corticostriatal circuitry that are reversed by BDNF in early withdrawal.

Authors:  Jacqueline F McGinty; Agnieska Zelek-Molik; Wei-Lun Sun
Journal:  Brain Res       Date:  2014-09-28       Impact factor: 3.252

7.  The self-administration of rapidly delivered cocaine promotes increased motivation to take the drug: contributions of prior levels of operant responding and cocaine intake.

Authors:  Karim Bouayad-Gervais; Ellie-Anna Minogianis; Daniel Lévesque; Anne-Noël Samaha
Journal:  Psychopharmacology (Berl)       Date:  2014-04-22       Impact factor: 4.530

8.  Different functional domains measured by cocaine self-administration under the progressive-ratio and punishment schedules in male Wistar rats.

Authors:  Udita Datta; Mariangela Martini; WenLin Sun
Journal:  Psychopharmacology (Berl)       Date:  2017-12-06       Impact factor: 4.530

Review 9.  Using metabotropic glutamate receptors to modulate cocaine's synaptic and behavioral effects: mGluR1 finds a niche.

Authors:  Jessica A Loweth; Kuei Y Tseng; Marina E Wolf
Journal:  Curr Opin Neurobiol       Date:  2013-02-04       Impact factor: 6.627

10.  Marked global reduction in mGluR5 receptor binding in smokers and ex-smokers determined by [11C]ABP688 positron emission tomography.

Authors:  Funda Akkus; Simon M Ametamey; Valerie Treyer; Cyrill Burger; Anass Johayem; Daniel Umbricht; Baltazar Gomez Mancilla; Judit Sovago; Alfred Buck; Gregor Hasler
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.